Citation Impact
Citing Papers
In vivo imaging of hydrogen peroxide production in a murine tumor model with a chemoselective bioluminescent reporter
2010 StandoutNobel
Strategy for Dual-Analyte Luciferin Imaging: In Vivo Bioluminescence Detection of Hydrogen Peroxide and Caspase Activity in a Murine Model of Acute Inflammation
2013 StandoutNobel
Characteristics and Roles of Exosomes in Cardiovascular Disease
2017
Comprehensive genomic characterization of head and neck squamous cell carcinomas
2015 StandoutNature
Nitro-fatty Acid Formation and Signaling
2008
Epidemic Inflammation: Pondering Obesity
2008
Nitro-fatty Acid Reaction with Glutathione and Cysteine
2007
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis
2013 Standout
β-Arrestin-mediated Signaling Regulates Protein Synthesis
2008 StandoutNobel
Nox4 regulates Nrf2 and glutathione redox in cardiomyocytes in vivo
2011
Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice
2010
Reversible Post-translational Modification of Proteins by Nitrated Fatty Acids in Vivo
2006
β-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation
2009 StandoutNobel
Analysis of the human monocyte-derived macrophage transcriptome and response to lipopolysaccharide provides new insights into genetic aetiology of inflammatory bowel disease
2017
The Effect of Valsartan, Captopril, or Both on Atherosclerotic Events After Acute Myocardial Infarction
2006
Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease
2015
The Many Faces of PPARγ
2005
S-Nitrosylation of β-Arrestin Regulates β-Adrenergic Receptor Trafficking
2008 StandoutNobel
Apoptotic cascade initiated by angiotensin II in neonatal cardiomyocytes: role of DNA damage
2003
Enhanced angiogenesis in obesity and in response to PPARγ activators through adipocyte VEGF and ANGPTL4 production
2008
Molecular Alterations in a Mouse Cardiac Model of Friedreich Ataxia
2017
The coming of age of chaperone-mediated autophagy
2018
Responses to reductive stress in the cardiovascular system
2016
Liver Regeneration
2006
Identification and Importance of Brown Adipose Tissue in Adult Humans
2009 Standout
Nrf2-Keap1 signaling in oxidative and reductive stress
2018 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Increased Angiogenesis Protects against Adipose Hypoxia and Fibrosis in Metabolic Disease-resistant 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD1)-deficient Mice
2011 StandoutNobel
Validation of the multiple sensor mechanism of the Keap1-Nrf2 system
2012
Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor
2010
Hallmarks of aging: An expanding universe
2023 Standout
Head and neck cancer
2008 Standout
Nitro-fatty Acid Metabolome: Saturation, Desaturation, β-Oxidation, and Protein Adduction
2008
G protein-coupled receptor interacting proteins: Emerging roles in localization and signal transduction
2002
Activation of Extracellular Signal-Activated Kinase by Angiotensin II-Induced Gq-Independent Epidermal Growth Factor Receptor Transactivation
2004
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
The Keap1–Nrf2 system and diabetes mellitus
2014
Regulation of stress signaling pathways by nitro-fatty acids
2018
Structure of the BTB Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist CDDO
2014
Nrf2 deficiency prevents reductive stress-induced hypertrophic cardiomyopathy
2013
The discovery of nitro-fatty acids as products of metabolic and inflammatory reactions and mediators of adaptive cell signaling
2018
Redox regulation of electrophilic signaling by reactive persulfides in cardiac cells
2017
Scleroderma
2009 Standout
PPAR gamma 2 Prevents Lipotoxicity by Controlling Adipose Tissue Expandability and Peripheral Lipid Metabolism
2007
Effects of iron overload on chronic metabolic diseases
2014
Nonresolving Inflammation
2010 Standout
Electrophilic Nitro-fatty Acids Activate NRF2 by a KEAP1 Cysteine 151-independent Mechanism
2011
Crosstalk Coregulation Mechanisms of G Protein-Coupled Receptors and Receptor Tyrosine Kinases
2006
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases
2013
PRDM16 controls a brown fat/skeletal muscle switch
2008 StandoutNature
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
2007 StandoutNature
Endoplasmic reticulum stress and Nrf2 signaling in cardiovascular diseases
2015
Super-Enhancers in the Control of Cell Identity and Disease
2013 Standout
PPARγ: A Critical Determinant of Body Fat Distribution in Humans and Mice
2005
Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus
2004
Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis
2006
Myokines and adipokines: Involvement in the crosstalk between skeletal muscle and adipose tissue
2016
Graves' Ophthalmopathy
2010 Standout
The different shades of fat
2014 Nature
eNOS Knockout Mice with Advanced Diabetic Nephropathy Have Less Benefit from Renin-Angiotensin Blockade than from Aldosterone Receptor Antagonists
2009
The synthetic triterpenoid, RTA 405, increases the glomerular filtration rate and reduces angiotensin II–induced contraction of glomerular mesangial cells
2012
The Vascular Endothelium in Hypertension
2006
Peroxisome Proliferator‐Activated Receptors in the Modulation of the Immune/Inflammatory Response in Atherosclerosis
2008
Transcriptional control of adipocyte formation
2006 Standout
Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists
2004
Brown adipose tissue thermogenic adaptation requires Nrf1-mediated proteasomal activity
2018 StandoutNobel
Hypoxia Rescues Frataxin Loss by Restoring Iron Sulfur Cluster Biogenesis
2019 StandoutNobel
Disruption of Nrf2/ARE signaling impairs antioxidant mechanisms and promotes cell degradation pathways in aged skeletal muscle
2012
Association of Nuclear Factor‐Erythroid 2‐Related Factor 2, Thioredoxin Interacting Protein, and Heme Oxygenase‐1 Gene Polymorphisms with Diabetes and Obesity in Mexican Patients
2016
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
Synthetic Oleanane Triterpenoids: Multifunctional Drugs with a Broad Range of Applications for Prevention and Treatment of Chronic Disease
2012
Activated Human T Lymphocytes Express Cyclooxygenase-2 and Produce Proadipogenic Prostaglandins that Drive Human Orbital Fibroblast Differentiation to Adipocytes
2006
What We Talk About When We Talk About Fat
2014 Standout
β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection
2007 StandoutNobel
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
The unfolded protein response transducer IRE1α prevents ER stress‐induced hepatic steatosis
2011
Adipocyte differentiation from the inside out
2006 Standout
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Discovery of a small-molecule inhibitor and cellular probe of Keap1–Nrf2 protein–protein interaction
2013
Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways
2014
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
2015 Standout
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
2006 Standout
Exploring the full spectrum of macrophage activation
2008 Standout
Electrophilic nitroalkene-tocopherol derivatives: synthesis, physicochemical characterization and evaluation of anti-inflammatory signaling responses
2018
Chronic blockade of the AT2 receptor with PD123319 impairs insulin signaling in C57BL/6 mice
2016
Characterization of novel small-molecule NRF2 activators: Structural and biochemical validation of stereospecific KEAP1 binding
2016
The Nuclear Factor Erythroid 2–Related Factor 2 Activator Oltipraz Attenuates Chronic Hypoxia–Induced Cardiopulmonary Alterations in Mice
2013
Sustained Activation of Nuclear Erythroid 2-Related Factor 2/Antioxidant Response Element Signaling Promotes Reductive Stress in the Human Mutant Protein Aggregation Cardiomyopathy in Mice
2010
Novel Role of NADPH Oxidase in Angiogenesis and Stem/Progenitor Cell Function
2009
Role of Angiotensin II–Regulated Apoptosis Through Distinct AT 1 and AT 2 Receptors in Neointimal Formation
2002
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
Nicotinamide Adenine Dinucleotide Phosphate Oxidase-4–Dependent Upregulation of Nuclear Factor Erythroid–Derived 2-Like 2 Protects the Heart During Chronic Pressure Overload
2014
Receptor‐mediated tobacco toxicity: cooperation of the Ras/Raf‐1/MEK1/ERK and JAK‐2/STAT‐3 pathways downstream of a7 nicotinic receptor in oral keratinocytes
2006
Regulatory circuits controlling white versus brown adipocyte differentiation
2006
TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype
2008
Luminescent Chemodosimeters for Bioimaging
2012 Standout
Human Papillomavirus (HPV) Upregulates the Cellular Deubiquitinase UCHL1 to Suppress the Keratinocyte's Innate Immune Response
2013
Adipose Deficiency of Nrf2 in ob/ob Mice Results in Severe Metabolic Syndrome
2012
Role of Mitochondrial Dysfunction in Insulin Resistance
2008
Fat and Beyond: The Diverse Biology of PPARγ
2008 Standout
Chemical Biology of Peroxynitrite: Kinetics, Diffusion, and Radicals
2009
Diabetic Cardiomyopathy
2018 Standout
Heterozygous α 2A -adrenergic receptor mice unveil unique therapeutic benefits of partial agonists
2002 StandoutNobel
New Synthetic Triterpenoids: Potent Agents for Prevention and Treatment of Tissue Injury Caused by Inflammatory and Oxidative Stress
2011
Genetic variants of nuclear factor erythroid‐derived 2‐like 2 associated with the complications in Han descents with type 2 diabetes mellitus of Northeast China
2016
Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPARγ–Modulating Activity
2004
Association between the NF-E2 Related Factor 2 Gene Polymorphism and Oxidative Stress, Anti-Oxidative Status, and Newly-Diagnosed Type 2 Diabetes Mellitus in a Chinese Population
2015
Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes
2017
Beyond the G Protein
2005
Deletion of Angiotensin II Type 2 Receptor Exaggerated Atherosclerosis in Apolipoprotein E–Null Mice
2005
Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway
2014
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
Pathological Ventricular Remodeling
2013
Activation of mTOR/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation
2011
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
2011
Role of the Molybdoflavoenzyme Aldehyde Oxidase Homolog 2 in the Biosynthesis of Retinoic Acid: Generation and Characterization of a Knockout Mouse
2008
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Mechanisms of Diabetic Complications
2013 Standout
Iron-Deficiency Anemia
2015 Standout
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
2007 StandoutNobel
The Mononuclear Molybdenum Enzymes
2014 Standout
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Inhibition of JNK by novel curcumin analog C66 prevents diabetic cardiomyopathy with a preservation of cardiac metallothionein expression
2014
Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
2006 StandoutScience
Derivative of Bardoxolone Methyl, dh404, in an Inverse Dose-Dependent Manner Lessens Diabetes-Associated Atherosclerosis and Improves Diabetic Kidney Disease
2014
The β Subunit of Voltage-Gated Ca2+Channels
2010
Redox-Dependent Anti-Inflammatory Signaling Actions of Unsaturated Fatty Acids
2013
Works of Taixing Cui being referenced
Nrf2 Protects Against Maladaptive Cardiac Responses to Hemodynamic Stress
2009
Triterpenoid Dihydro-CDDO-Trifluoroethyl Amide Protects against Maladaptive Cardiac Remodeling and Dysfunction in Mice: A Critical Role of Nrf2
2012
Dihydro-CDDO-Trifluoroethyl Amide (dh404), a Novel Nrf2 Activator, Suppresses Oxidative Stress in Cardiomyocytes
2009
Dihydro-CDDO-trifluoroethyl amide suppresses inflammatory responses in macrophages via activation of Nrf2
2014
Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation
2013
ATRAP, Novel AT1 Receptor Associated Protein, Enhances Internalization of AT1 Receptor and Inhibits Vascular Smooth Muscle Cell Growth
2000
INCREASED SECRETION OF TUMOUR NECROSIS FACTOR AND INTERLEUKIN 6 FROM ISOLATED, PERFUSED LIVER OF RATS AFTER PARTIAL HEPATECTOMY
2001
A critical role of cardiac fibroblast-derived exosomes in activating renin angiotensin system in cardiomyocytes
2015
CYLD-Mediated Signaling and Diseases
2014
Nitro-linoleic acid inhibits vascular smooth muscle cell proliferation via the Keap1/Nrf2 signaling pathway
2007
Targeting Nrf2 by dihydro‐CDDO‐trifluoroethyl amide enhances autophagic clearance and viability of β‐cells in a setting of oxidative stress
2014
Nrf2 enhances myocardial clearance of toxic ubiquitinated proteins
2014
Nitrated Fatty Acids: Endogenous Anti-inflammatory Signaling Mediators
2006
Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell
2001
Degradation of AF1Q by chaperone-mediated autophagy
2014
Up-regulation of p27kip1 contributes to Nrf2-mediated protection against angiotensin II-induced cardiac hypertrophy
2011
Regulation of Inhibitory Protein-κB and Monocyte Chemoattractant Protein-1 by Angiotensin II Type 2 Receptor-Activated Src Homology Protein Tyrosine Phosphatase-1 in Fetal Vascular Smooth Muscle Cells
2003
Tumor Necrosis Factor-α Inhibits Growth Factor–Mediated Cell Proliferation Through SHP-1 Activation in Endothelial Cells
2002
Selective disruption of PPARγ2 impairs the development of adipose tissue and insulin sensitivity
2004
Diabetic Downregulation of Nrf2 Activity via ERK Contributes to Oxidative Stress–Induced Insulin Resistance in Cardiac Cells In Vitro and In Vivo
2011
Angiotensin II Subtype 2 Receptor Activation Inhibits Insulin-Induced Phosphoinositide 3-Kinase and Akt and Induces Apoptosis in PC12W Cells
2002
ACE Inhibitor Improves Insulin Resistance in Diabetic Mouse Via Bradykinin and NO
2002
Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-κB
2012
Important Role of Nitric Oxide in the Effect of Angiotensin-Converting Enzyme Inhibitor Imidapril on Vascular Injury
2003
Ubiquitin Carboxyl-Terminal Hydrolase L1, a Novel Deubiquitinating Enzyme in the Vasculature, Attenuates NF-κB Activation
2007
Cross Talk between Angiotensin II Type 1 and Type 2 Receptors: Cellular Mechanism of Angiotensin Type 2 Receptor-Mediated Cell Growth Inhibition.
1999
Fluvastatin Enhances the Inhibitory Effects of a Selective AT 1 Receptor Blocker, Valsartan, on Atherosclerosis
2004
Angiotensin II Type-1 Receptor Blocker Valsartan Enhances Insulin Sensitivity in Skeletal Muscles of Diabetic Mice
2004
Nitroalkenes Suppress Lipopolysaccharide-Induced Signal Transducer and Activator of Transcription Signaling in Macrophages: A Critical Role of Mitogen-Activated Protein Kinase Phosphatase 1
2008
Nitrolinoleic acid: An endogenous peroxisome proliferator-activated receptor γ ligand
2005
Irisin Stimulates Browning of White Adipocytes Through Mitogen-Activated Protein Kinase p38 MAP Kinase and ERK MAP Kinase Signaling
2013
Rad GTPase Deficiency Leads to Cardiac Hypertrophy
2007
Role of AT2receptor in the brain in regulation of blood pressure and water intake
2003
Targeting the Nrf2 pathway against cardiovascular disease
2009
Trans-inactivation of Receptor Tyrosine Kinases by Novel Angiotensin II AT2 Receptor-interacting Protein, ATIP
2004
Nicotine Enhances Angiotensin II-Induced Mitogenic Response in Vascular Smooth Muscle Cells and Fibroblasts
2003
Nrf2 Deficiency Exaggerates Doxorubicin-Induced Cardiotoxicity and Cardiac Dysfunction
2014
Hepcidin Destabilizes Atherosclerotic Plaque Via Overactivating Macrophages After Erythrophagocytosis
2012
Fluvastatin Enhances the Inhibitory Effects of a Selective Angiotensin II Type 1 Receptor Blocker, Valsartan, on Vascular Neointimal Formation
2003